ask="2.72"
ask_size="500"
average_daily_volume="960937"
bid="2.51"
bid_size="200"
book_value="0.34"
change="-0.24"
change_from_200_day_moving_average="0.92"
change_from_50_day_moving_average="0.81"
change_from_52_week_high="-2.49"
change_From_52_week_low="1.50"
change_in_percent="-8.42%"
close="2.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4532000"
high="2.88"
high_52_weeks="5.10"
last_trade_date="2/27/2017"
last_trade_price="2.61"
last_trade_size="3120"
last_trade_time="4:00pm"
low="2.51"
low_52_weeks="1.11"
market_capitalization="25.02M"
moving_average_200_day="1.69"
moving_average_50_day="1.80"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="2.61"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+54.53%"
percent_change_from_50_day_moving_average="+44.95%"
percent_change_from_52_week_high="-48.82%"
percent_change_from_52_week_low="+135.14%"
previous_close="2.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.41"
price_per_sales="53.68"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="1256241"
weeks_range_52="1.11 - 5.10"
